Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eujin International is a South Korean healthcare company that specializes in the development and global distribution of medical aesthetic products. The company provides a comprehensive portfolio of dermatological solutions, including botulinum toxins, hyaluronic acid dermal fillers, and advanced mesotherapy treatments. As a prominent player in the international "K-Beauty" medical sector, Eujin International focuses on delivering pharmaceutical-grade products that address facial rejuvenation and anti-aging needs. Their business operations span across manufacturing, quality control, and the export of aesthetic devices and pharmaceuticals to clinics worldwide. The company is recognized for its commitment to high-quality standards and its role in expanding the reach of Korean aesthetic innovations to global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eujin International.